... important findings at the San Antonio Breast Cancer Symposium Dec. ... Phoenix Molecular Designs, Pieris Pharmaceuticals, Puma Biotechnology, ...
News
- SABCS: Subgroup analysis of trastuzumab derux | EurekAlert!
- Oncolytics Biotech® Presents Positive Interim Safety Update from Phase 2 Triple-Negative ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) announced a ... in a poster presentation at the 2021 San Antonio Breast Cancer Symposium (SABCS).
- Biotechs Share Promising Breast Cancer Data at San Antonio Symposium | BioSpace
The 2021 San Antonio Breast Cancer Symposium is meeting December 7–10 at the Henry B. Gonzalez Convention Center in San Antonio, Texas, ...
- Infinity Pharmaceuticals Inc. (INFI) stock plunged following the investor event happening ...
Infinity Pharmaceuticals is a medical biotechnology business working on ... In the San Antonio Breast Cancer Symposium (SABCS 2021), the company ...
- Big Trend Occurring in Triple-Negative Breast Cancer Treatment Is The Shift Towards ...
... NEWS: Oncolytics Biotech® Presents Positive Interim Safety Update from Phase 2 Triple-Negative Breast Cancer Trial at the 2021 San Antonio ...